The modest 1.2% stock uptick suggests investors are cautiously digesting progress on production partnerships and regulatory milestones, without clear excitement from the company’s cautious regulatory timeline and capital-intensive execution phase.

• Signed a production agreement with Allseas to complete and operate the first commercial polymetallic nodule collection system, signaling progress toward commercial readiness.
• Expecting final permit issuance from NOAA in Q1 2027, but the regulatory process remains lengthy with multiple public comment periods and no mandatory timeline.
• Allseas will fund a significant portion of preproduction costs, repayable after production commences, partially mitigating upfront capital risk.
• Offshore operations design includes continuous nodule collection, transfer logistics, and synchronized vessel movements, highlighting operational complexity.
• No new guidance or financial metrics disclosed; forward-looking statements emphasize risks and uncertainties inherent in project execution and regulatory approvals.